WHITTIER TRUST CO OF NEVADA INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITTIER TRUST CO OF NEVADA INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$57,082
-1.5%
3,6900.0%0.00%0.0%
Q2 2023$57,968
-5.6%
3,690
-1.1%
0.00%0.0%
Q1 2023$61,430
+5.6%
3,7300.0%0.00%0.0%
Q4 2022$58,187
+21.2%
3,7300.0%0.00%0.0%
Q3 2022$48,000
-12.7%
3,730
-5.2%
0.00%0.0%
Q2 2022$55,0000.0%3,936
+2.1%
0.00%0.0%
Q1 2022$55,000
+3.8%
3,8560.0%0.00%0.0%
Q4 2021$53,000
+39.5%
3,856
+68.2%
0.00%0.0%
Q3 2021$38,000
+375.0%
2,292
+380.5%
0.00%
Q2 2021$8,000
-11.1%
4770.0%0.00%
Q1 2021$9,0000.0%4770.0%0.00%
Q4 2020$9,0000.0%4770.0%0.00%
-100.0%
Q3 2020$9,0000.0%4770.0%0.00%0.0%
Q2 2020$9,000
+28.6%
4770.0%0.00%0.0%
Q1 2020$7,000
-22.2%
4770.0%0.00%0.0%
Q4 2019$9,000
+12.5%
4770.0%0.00%0.0%
Q3 2019$8,0000.0%4770.0%0.00%0.0%
Q2 2019$8,000
-20.0%
4770.0%0.00%0.0%
Q1 2019$10,0004770.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders